State Street Corp Novavax Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Novavax Inc stock. As of the latest transaction made, State Street Corp holds 7,687,951 shares of NVAX stock, worth $66.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,687,951

Previous 6,066,179 26.73%

Holding current value

$66.9 Million

Previous $76.8 Million 26.43%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $17.4 Million - $27.7 Million	1,621,772 Added 26.73%	7,687,951 $97.1 Million
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $42.2 Million - $227 Million	-10,840,391 Reduced 64.12%	6,066,179 $76.8 Million
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $491,413 - $786,783	130,695 Added 0.78%	16,906,570 $80.8 Million
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $31.7 Million - $50.6 Million	6,601,258 Added 64.88%	16,775,875 $80.5 Million
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $10.2 Million - $14.7 Million	-1,504,811 Reduced 12.88%	10,174,617 $73.7 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $3.85 Million - $5.49 Million	576,803 Added 5.2%	11,679,428 $86.8 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $29 Million - $62.7 Million	5,026,107 Added 82.71%	11,102,625 $76.9 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $21.5 Million - $60.6 Million	2,421,090 Added 66.23%	6,076,518 $62.5 Million
Q3 2022 Nov 15, 2022	BUY	$18.2 - $76.12 $12.5 Million - $52.4 Million	688,564 Added 23.21%	3,655,428 $66.5 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $17.1 Million - $35.5 Million	471,322 Added 18.89%	2,966,864 $153 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $41.6 Million - $85.2 Million	596,322 Added 31.4%	2,495,542 $184 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $20.5 Million - $33.3 Million	152,593 Added 8.74%	1,899,220 $272 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $9.47 Million - $14.4 Million	53,237 Added 3.14%	1,746,627 $362 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $30.4 Million - $64.8 Million	251,437 Added 17.44%	1,693,390 $360 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $32.1 Million - $90.9 Million	-284,229 Reduced 16.47%	1,441,953 $261 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $1.36 Million - $2.42 Million	17,323 Added 1.01%	1,726,182 $192 Million
Q3 2020 Nov 10, 2020	SELL	$79.44 - $178.51 $48 Million - $108 Million	-604,488 Reduced 26.13%	1,708,859 $185 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $24 Million - $145 Million	1,733,715 Added 299.11%	2,313,347 $193 Million
Q1 2020 May 11, 2020	BUY	$3.93 - $16.0 $2.28 Million - $9.27 Million	579,632 New	579,632 $7.87 Million

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Novavax Inc Transaction History